How does Besponsa work to treat Acute Lymphoblastic Leukemia (ALL)?
Besponsa (inotuzumab ozogamicin) works to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) by binding to B-cell ALL cancer cells that express the CD22 antigen to block the growth of cancerous cells.
B-cell acute lymphoblastic leukemia (B-ALL) is an aggressive type of leukemia in which the bone marrow makes too many B-cell lymphocytes. It can be fatal within a matter of months if left untreated. Almost all B-ALL patients have cancer cells that express the CD22 antigen.
Besponsa is an antibody-drug conjugate (ADC) composed of a monoclonal antibody (mAb) that targets the CD22 antigen linked to a cytotoxic agent. When Besponsa binds to the CD22 antigen on B-cells, it is internalized into the cell, where the cytotoxic agent calicheamicin is released causing cell death.
Besponsa is indicated for the treatment of relapsed or refractory CD22-positive B-cell
precursor acute lymphoblastic leukemia (ALL) in adult and pediatric patients
1 year and older.
Besponsa is administered as a one-hour intravenous infusion.
The prescribing information for Besponsa includes a boxed warning for severe liver damage (hepatotoxicity). Serious side effects include a decrease in blood cell and platelet production (myelosuppression), infusion-related reactions and problems with the heart’s electrical pulses (QT interval prolongation).
Common side effects of Besponsa include low levels of platelets (thrombocytopenia), low levels of certain white blood cells (neutropenia, leukopenia), infection, low levels of red blood cells (anemia), fatigue, severe bleeding (hemorrhage), fever (pyrexia), nausea, headache, low levels of white blood cells with fever (febrile neutropenia), liver damage (transaminases and/or gamma-glutamyltransferase increased), abdominal pain and high levels of bilirubin in the blood (hyperbilirubinemia).
Related questions
Read next
How much does Tecartus cost?
Tecartus costs $373,000 as a one time CAR-T immunotherapy cancer treatment. Most people do not pay for this medicine themselves. It is a personalized medicine engineered from a patient’s own white blood cells. Costs may be covered by your insurance plan, patient assistance programs, or financial resources offered through the manufacturer. Continue reading
Gleevec vs Sprycel vs Tasigna - how do they compare?
Gleevec, Sprycel and Tasigna are all prescription medicines used to treat chronic myelogenous leukemia (blood cancer). Gleevec and Sprycel are also approved for other types of cancers and tumors. These drugs are all classified as BCR-ABL kinase inhibitors and block the enzyme BCR-ABL tyrosine kinase, which is an important pathway in the development of leukemia. Continue reading
How much does Blincyto (blinatumomab) cost?
The cost of a Blincyto (blinatumomab) vial is approximately $5,427 per 35 microgram (mcg) single-dose vial for injection. The overall cost for your therapy will also depend upon the length of treatment. Most people do not pay out-of-pocket for the full price of Blincyto. Continue reading
Related medical questions
- How long does it take Sprycel (dasatinib) to start working?
- Is there a generic for Gleevec?
- Is Sprycel a chemotherapy drug?
- How does Gleevec (imatinib) work?
- What is the cost of Kymriah?
- Is Tecartus a one-time treatment?
- Is Tasigna a form of chemotherapy?
- Is Blincyto (blinatumomab) chemotherapy?
- Can I take Gleevec while pregnant?
- How is Blincyto taken / administered?
- How does Asparlas (calaspargase pegol-mknl) compare to Oncaspar (pegaspargase)?
- How is Kymriah administered?
- What type of drug is Kymriah (tisagenlecleucel)?
- What type of cancer is Daurismo (glasdegib) used to treat?
- Prednisone: What are 12 Things You Should Know?
- How long does methotrexate stay in your system?
- What is Zydelig used for and how does it work?
- What type of leukemia is Xospata (gilteritinib) used to treat?
Drug information
- Besponsa Information for Consumers
- Besponsa prescribing info & package insert (for Health Professionals)
- Side Effects of Besponsa (detailed)
Related support groups
- Besponsa (2 questions, 4 members)
- Acute Lymphoblastic Leukemia (22 questions, 15 members)
- Leukemia (14 questions, 78 members)